Durlach J. Chronic fatigue syndrome and chronic primary magnesium deficiency (CFS and CPMD).
Magnes Res. 1992;5:68.
Howard JM, Davies S, Hunnisett A. Magnesium and chronic fatigue syndrome [letter].
Lancet. 1992;340:426.
Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome.
Lancet. 1991;337:757 - 760.
Cleare AJ, Heap E, Malhi GS, et al. Low--dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
Lancet. 1999;353:455 - 458.
Jeffcoate WJ. Chronic fatigue syndrome and functional hypoadrenia-fighting vainly the old ennui [letter].
Lancet. 1999;353:424 - 425.
Dessein PH, Shipton EA. Hydrocortisone and chronic fatigue syndrome [letter].
Lancet. 1999;353:1618.
Baschetti R
.
Hydrocortisone and chronic fatigue syndrome [letter]
Lancet.
1999;353:1618.
Rea T, Buchwald D. Hydrocortisone and chronic fatigue syndrome [letter].
Lancet. 1999;353:1618 - 1619.
Shepherd C. Hydrocortisone and chronic fatigue syndrome [letter].
Lancet. 1999;353:1619 - 1620.
Deale A, Chalder T, Wessely S. Commentary on: randomised, double-blind, placebo-controlled trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Br J Psychiatry. 1998;172:491 - 492.
Wearden AJ, Morriss RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Br J Psychiatry. 1998;172:485 - 490.
Lynch S, Fraser J. Fluoxetine and graded exercise in chronic fatigue syndrome [letter].
Br J Psychiatry. 1998;173:353.
Everitt BS. Analysis of drop-out data in treatment trials [letter].
Br J Psychiatry. 1998;173:271.
Peterson PK, Pheley A, Schroeppel J, et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome.
Arch Intern Med. 1998;158:908 - 914.
Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome.
Acta Neurol Scand. 1990;82:209 - 216.
Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA.
Acta Neurol Scand. 1999;99:112 - 116.
Forsyth LM, Preuss HG, MacDowell AL, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome.
Ann Allergy. 1999;82:185 - 191.
Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of chronic fatigue syndrome.
Neuropsychobiology. 1997;35:16 - 23.
Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of chronic fatigue syndrome.
Neuropsychobiology. 1997;35:16 - 23.
See DM, Broumand N, Sahl L, et al. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency patients.
Immunopharmacology. 1997;35:229 - 235.
Himmel PB, Seligman TM. A pilot study employing dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome.
J Clin Rheumatol. 1999;5:56 - 59.
Cunha BA. Beta-carotene stimulation of natural killer cell activity in adult patients with chronic fatigue syndrome.
CFIDS Chronicle Physicians' Forum. Fall 1993:18 - 19.
Heath M, Klein NC, Cunha BA. Dose dependent effects of beta carotene therapy in chronic fatigue syndrome [abstract].
Clin Res. 1994;42:345A.
Peterson PK, Pheley A, Schroeppel J, et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome.
Arch Intern Med. 1998;158:908 - 914.
Martin RWY, Ogston SA, Evans JR. Effects of vitamin and mineral supplementation on symptoms associated with chronic fatigue syndrome with Coxsackie B antibodies.
J Nutr Med. 1994;4:11 - 23.
Brouwers FM, Van Der Werf S, Bleijenberg G, et al. The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind randomized controlled trial.
QJM.
2002;95:677-683.
Kuratsune, H. Effect of Kampo Medicine, "Hochu-ekki-to," on chronic fatigue syndrome.
Clinic and Research. 1997;74:1837 - 1845.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.